New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
07:35 EDTABT, MJN, NSRGY, DANOYDanone in talks to sell medical nutrition unit, may seek formula maker, FT says
Danone (DANOY) is being advised by JPMorgan (JPM) and stands to raise up to EUR5B from a potential sale of most of its medical nutrition unit, according to Financial Times, which noted that the company is in talks about the division with Nestle (NSRGY) and other potential buyers. People familiar with the talks say Danone could spend any proceeds on acquiring other infant formula producers. The Fly notes that other baby formula makers include Mead Johnson (MJN) and Abbott (ABT). Reference Link
News For DANOY;MJN;ABT;NSRGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
06:29 EDTDANOYDanone considering sale of Yakult stake, Bloomberg reports
Danone (DANOY) is contemplating the sale of its 20% stake in Japanese dairy-drink producer Yakult Honsha, Bloomberg reports, citing people familiar with the matter. The stake is worth about $2B, Bloomberg adds. Reference Link
November 19, 2014
14:11 EDTDANOYFresenius, Permira made joint bid for Danone nutrition unit, WSJ reports
Fresenius SE, the German parent company of Fresenius Medical (FMS), and buyout firm Permira made a joint bid for Danone’s (DANOY) medical nutrition business, according to The Wall Street Journal, citing people familiar with the matter. Danone has set early next week as the deadline for others to bid, though one of the people said the joint bid is currently the only one on the table, the report noted. Reference Link
13:47 EDTDANOYFresenius, Permira made joint bid for Danone nutrition unit, DJ reports
Subscribe for More Information
November 18, 2014
08:43 EDTMJNMead Johnson sees FY14 adjusted EPS $3.64-$3.72, consensus $3.72
Says excess cash flow and borring capacity provides flexibility to grow through M&A, return cash to shareholders via dividends and buybacks. Says will consider incremental demand-generation investments in 2015 in light of anticipated gross margin improvement. Sees long-term earnings growth at or above the rate of revenue growth. Sees revenue growth within the top quartile of peer group. Sees dividend growth at or above the rate of EPS growth. Comments from slides that will be presented at the Morgan Stanley Global Consumer Conference.
07:30 EDTMJNMorgan Stanley to hold a conference
Subscribe for More Information
November 17, 2014
08:16 EDTABTZoetis to purchase assets of Abbott Animal Health for about $255M
Subscribe for More Information
08:15 EDTABTZoetis to purchase assets of Abbott Animal Health for about $255M
07:21 EDTDANOY, NSRGYDanone mulls IPO for nutrition unit as sale talks disappoint, Reuters says
Subscribe for More Information
November 14, 2014
05:42 EDTNSRGYNestle to explore strategic options for development of Davigel
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use